1114 related articles for article (PubMed ID: 29453043)
21. Targeted inhibitors of P-glycoprotein increase chemotherapeutic-induced mortality of multidrug resistant tumor cells.
Nanayakkara AK; Follit CA; Chen G; Williams NS; Vogel PD; Wise JG
Sci Rep; 2018 Jan; 8(1):967. PubMed ID: 29343829
[TBL] [Abstract][Full Text] [Related]
22. Strategies for overcoming ABC-transporters-mediated multidrug resistance (MDR) of tumor cells.
Borowski E; Bontemps-Gracz MM; Piwkowska A
Acta Biochim Pol; 2005; 52(3):609-27. PubMed ID: 16175236
[TBL] [Abstract][Full Text] [Related]
23. The therapeutic potential of targeting ABC transporters to combat multi-drug resistance.
Bugde P; Biswas R; Merien F; Lu J; Liu DX; Chen M; Zhou S; Li Y
Expert Opin Ther Targets; 2017 May; 21(5):511-530. PubMed ID: 28335655
[TBL] [Abstract][Full Text] [Related]
24. Models used to screen for the treatment of multidrug resistant cancer facilitated by transporter-based efflux.
Willers C; Svitina H; Rossouw MJ; Swanepoel RA; Hamman JH; Gouws C
J Cancer Res Clin Oncol; 2019 Aug; 145(8):1949-1976. PubMed ID: 31292714
[TBL] [Abstract][Full Text] [Related]
25. Multidrug resistance: Physiological principles and nanomedical solutions.
Kunjachan S; Rychlik B; Storm G; Kiessling F; Lammers T
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1852-1865. PubMed ID: 24120954
[TBL] [Abstract][Full Text] [Related]
26. Natural product modulators to overcome multidrug resistance in cancer.
Cort A; Ozben T
Nutr Cancer; 2015; 67(3):411-23. PubMed ID: 25649862
[TBL] [Abstract][Full Text] [Related]
27. Multidrug resistance: molecular mechanisms and clinical relevance.
Ling V
Cancer Chemother Pharmacol; 1997; 40 Suppl():S3-8. PubMed ID: 9272126
[TBL] [Abstract][Full Text] [Related]
28. Mechanisms and strategies to overcome multiple drug resistance in cancer.
Ozben T
FEBS Lett; 2006 May; 580(12):2903-9. PubMed ID: 16497299
[TBL] [Abstract][Full Text] [Related]
29. Improvement of conventional anti-cancer drugs as new tools against multidrug resistant tumors.
Dallavalle S; Dobričić V; Lazzarato L; Gazzano E; Machuqueiro M; Pajeva I; Tsakovska I; Zidar N; Fruttero R
Drug Resist Updat; 2020 May; 50():100682. PubMed ID: 32087558
[TBL] [Abstract][Full Text] [Related]
30. Marine Natural Products as Models to Circumvent Multidrug Resistance.
Long S; Sousa E; Kijjoa A; Pinto MM
Molecules; 2016 Jul; 21(7):. PubMed ID: 27399665
[TBL] [Abstract][Full Text] [Related]
31. Zafirlukast antagonizes ATP-binding cassette subfamily G member 2-mediated multidrug resistance.
Sun YL; Kathawala RJ; Singh S; Zheng K; Talele TT; Jiang WQ; Chen ZS
Anticancer Drugs; 2012 Sep; 23(8):865-73. PubMed ID: 22614107
[TBL] [Abstract][Full Text] [Related]
32. N,N-bis(cyclohexanol)amine aryl esters: the discovery of a new class of highly potent inhibitors of transporter-dependent multidrug resistance (MDR).
Teodori E; Dei S; Martelli C; Scapecchi S
Curr Top Med Chem; 2010; 10(17):1715-31. PubMed ID: 20645921
[TBL] [Abstract][Full Text] [Related]
33. ABC transporters in multidrug resistance and pharmacokinetics, and strategies for drug development.
Choi YH; Yu AM
Curr Pharm Des; 2014; 20(5):793-807. PubMed ID: 23688078
[TBL] [Abstract][Full Text] [Related]
34. Reversing multidrug resistance by tyrosine kinase inhibitors.
He M; Wei MJ
Chin J Cancer; 2012 Mar; 31(3):126-33. PubMed ID: 22237041
[TBL] [Abstract][Full Text] [Related]
35. Not only P-glycoprotein: Amplification of the ABCB1-containing chromosome region 7q21 confers multidrug resistance upon cancer cells by coordinated overexpression of an assortment of resistance-related proteins.
Genovese I; Ilari A; Assaraf YG; Fazi F; Colotti G
Drug Resist Updat; 2017 May; 32():23-46. PubMed ID: 29145976
[TBL] [Abstract][Full Text] [Related]
36. ABC Transporters in the Development of Multidrug Resistance in Cancer Therapy.
Dlugosz A; Janecka A
Curr Pharm Des; 2016; 22(30):4705-4716. PubMed ID: 26932159
[TBL] [Abstract][Full Text] [Related]
37. The modulation of ABC transporter-mediated multidrug resistance in cancer: a review of the past decade.
Kathawala RJ; Gupta P; Ashby CR; Chen ZS
Drug Resist Updat; 2015 Jan; 18():1-17. PubMed ID: 25554624
[TBL] [Abstract][Full Text] [Related]
38. Interaction of tyrosine kinase inhibitors with the MDR- related ABC transporter proteins.
Wang XK; Fu LW
Curr Drug Metab; 2010 Sep; 11(7):618-28. PubMed ID: 20812904
[TBL] [Abstract][Full Text] [Related]
39. Ascites Increases Expression/Function of Multidrug Resistance Proteins in Ovarian Cancer Cells.
Mo L; Pospichalova V; Huang Z; Murphy SK; Payne S; Wang F; Kennedy M; Cianciolo GJ; Bryja V; Pizzo SV; Bachelder RE
PLoS One; 2015; 10(7):e0131579. PubMed ID: 26148191
[TBL] [Abstract][Full Text] [Related]
40. Mouse ATP-Binding Cassette (ABC) Transporters Conferring Multi-Drug Resistance.
Li S; Zhang W; Yin X; Xing S; Xie HQ; Cao Z; Zhao B
Anticancer Agents Med Chem; 2015; 15(4):423-32. PubMed ID: 25929575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]